Gender
Non-Steroidal Anti-Inflammatory Agents, Excluding Aspirin (SHHS2) vs SHHS Visit Number
Visit 1 | Interim Follow-up Visit | Visit 2 | CVD Outcomes | |
---|---|---|---|---|
Total | - | - | 4,080 | - |
No | - | - | 2,960 | - |
Yes | - | - | 660 | - |
Unknown | - | - | 460 | - |
Non-Steroidal Anti-Inflammatory Agents, Excluding Aspirin (SHHS2) vs Gender
Visit 2
Male | Female | Total | |
---|---|---|---|
Total | 1,861 | 2,219 | 4,080 |
No | 1,387 | 1,573 | 2,960 |
Yes | 274 | 386 | 660 |
Unknown | 200 | 260 | 460 |
Non-Steroidal Anti-Inflammatory Agents, Excluding Aspirin (SHHS2) vs Race
Visit 2
White | Black | Other | Total | |
---|---|---|---|---|
Total | 3,587 | 256 | 237 | 4,080 |
No | 2,579 | 208 | 173 | 2,960 |
Yes | 583 | 34 | 43 | 660 |
Unknown | 425 | 14 | 21 | 460 |